

Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
You can purchase shares of iShares Neuroscience and Healthcare ETF (ARCA:IBRN) through any online brokerage.
There are no as such competitors for iShares Neuroscience and Healthcare ETF.
There is no analysis for iShares Neuroscience and Healthcare ETF to provide a consensus price target.
The stock price for iShares Neuroscience and Healthcare ETF (ARCA: IBRN) is $31.5979 last updated October 26, 2026 at 8:00 PM EDT.
There are no upcoming dividends for iShares Neuroscience and Healthcare ETF.
iShares Neuroscience and Healthcare ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares Neuroscience and Healthcare ETF.
The Fund seeks to track the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index (the Underlying Index), which measures the performance of equity securities of companies that are involved in the research, development or...